Circulating epithelial cells in patients with benign colon diseases

Clinical Chemistry

Volumn 58, Issue 5, 2012, Pages 936-940

  Pantel, Klaus ^a   Denève, Eric ^b   Nocca, David ^b   Coffy, Amandine ^c   Vendrell, Jean Pierre ^d   Maudelonde, Thierry ^e   Riethdorf, Sabine ^a   Alix Panabières, Catherine ^c,d,e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HÔPITAL SAINT ELOI   (France)

^c UNIV MONTPELLIER   (France)

^d University Medical Centre   (France)

^e HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; EPITHELIAL CELL ADHESION MOLECULE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CYTODIAGNOSIS; CANCER STAGING; CELL ASSAY; CELL VIABILITY; CIRCULATING EPITHELIUM CELL; CIRCULATING TUMOR CELL; COLON DIVERTICULOSIS; COLON POLYP; COLON TUMOR; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; ENDOMETRIOSIS; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD45; ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELL COUNT; COLONIC DISEASES; EPITHELIAL CELLS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; STAINING AND LABELING; YOUNG ADULT;

EID: 84860660477     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.175570     Document Type: Article

References (20)

1. Müller V, Alix-Panabières C, Pantel K. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies. Eur J Cancer 2010;46:1189-97.
2. Pantel K. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med 2010;16:398-406.
3. Hardingham J, Hewett P, Sage R, Finch J, Nuttall J, Kotasek D, Dobrovic A. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 2000;89:8-13. (Pubitemid 30078743)
4. Jung R, Petersen K, Krüger W, Wolf M, Wagener C, Zander A, Neumaier M. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999;81:870-3. (Pubitemid 29504699)
5. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91. (Pubitemid 39095313)
6. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2006;12:4218-24.
7. Riethdorf S, Fritsche H, Mueller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007;13: 920-8. (Pubitemid 46340368)
8. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of circulating tumor cells to tumor response, progressionfree survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26:3213-21.
9. Shaffer DR, Leversha MA, Danila DC, Lin O, Gonzalez-Espinoza R, Gu B, et al. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 2007;13:2023-9. (Pubitemid 46649868)
10. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R, Rafael S, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008;19: 935-8. (Pubitemid 351627310)
11. Antolovic D, Galindo L, Carstens A, Rahbari N, Buchler MW, Weitz J, Koch M. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies. BMC Biotechnol 2010;10:35.
12. Alix-Panabières C, Brouillet JP, Fabbro M, Yssel H, Rousset T, Maudelonde T, et al. Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients. J Immunol Methods 2005;299:177-88. (Pubitemid 40725934)
13. Alix-Panabières C, Rebillard X, Brouillet JP, Barbotte E, Iborra F, Segui B, et al. Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients. Clin Chem 2005; 51:1538-41. (Pubitemid 41060898)
14. Alix-Panabières C, Vendrell JP, Pelle O, Rebillard X, Riethdorf S, Muller V, et al. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 2007;53: 537-9. (Pubitemid 46447957)
15. Schwarzenbach H, Alix-Panabières C, Muller I, Letang N, Vendrell JP, Rebillard X, Pantel K. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 2009;15:1032-8.
16. Alix-Panabières C, Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res 2008;14:5013-21.
17. Alix-Panabières C, Vendrell JP, Slijper M, Pellé O, Barbotte E, Mercier G, et al. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res 2009;11:R39.
18. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subject or patients with nonmalignant diseases. Clin Cancer Res 2004;10:6897-904. (Pubitemid 39383039)
19. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
20. Coumans FA, Doggen CJ, Attard G, de Bono JS, Terstappen LW. All circulating EpCAM CK CD45 objects predict overall survival in castration-resistant prostate cancer. Ann Oncol 2010;21:1851-7.